Cargando…

Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level

BACKGROUND: Equitable access to essential medicines of maintained efficacy, safety, quality, and cost-effectiveness must be ensured by a well-functioning health system. This study aims to identify the determinants of patients’ access to medicines at the primary health care (PHC) level from the persp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizk, Hoda Ibrahim, Elkholy, Monira Mahmoud, Barakat, Abeer Abdou, Elsayed, Raghda Mostafa Mostafa, Abd El Fatah, Shaimaa A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806678/ https://www.ncbi.nlm.nih.gov/pubmed/33439381 http://dx.doi.org/10.1186/s42506-020-00062-x

Ejemplares similares

Global Pharmaceutical Manufacturing: Association for Accessible Medicines Perspective
por: Gaugh, David
Publicado: (2020)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
por: Ahmadiani, Saeed, et al.
Publicado: (2016)

Epidemiology of non-fatal injuries among Egyptian children: a community-based cross-sectional survey
por: Halawa, Eman Fawzy, et al.
Publicado: (2015)

Psychiatrists are stakeholders in improving access to controlled medicines
por: Scholten, Willem
Publicado: (2011)

Stakeholders’ Perspectives Regarding Supply Chain System of Pharmaceuticals and Vaccines in Pakistan: A Qualitative Study
por: Malik, Madeeha, et al.
Publicado: (2022)

Stakeholders' perspectives and use of web-based knowledge support for environmental information on pharmaceuticals
por: Linder, Elkanah, et al.
Publicado: (2023)

Access to medicines: relations with the institutionalization of pharmaceutical services
por: de Barros, Rafael Damasceno, et al.
Publicado: (2017)

Perceptions from pharmaceutical stakeholders on how the pharmaceutical budget is allocated in South Africa
por: Moodley, Lirosha, et al.
Publicado: (2021)

Stakeholders’ perspectives on Public Health Medicine in South Africa
por: Zweigenthal, Virginia E. M., et al.
Publicado: (2019)

Cronkhite-Canada syndrome: First case report from Egypt and North Africa
por: Alzamzamy, Ahmed Elsayed, et al.
Publicado: (2022)

Stakeholder Perspectives on Access to IBD Care: Proceedings From a National IBD Access Summit
por: MacDonald, Sonja, et al.
Publicado: (2022)

Stakeholders' Attitude to Genetically Modified Foods and Medicine
por: Amin, Latifah, et al.
Publicado: (2013)

Stakeholders’ perspectives on access-to-medicines policy and research priorities in Latin America and the Caribbean: face-to-face and web-based interviews
por: Azeredo, Thiago Botelho, et al.
Publicado: (2014)

Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry
por: Jandhyala, Ravi
Publicado: (2022)

Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence
por: Alshawwa, Samar Zuhair, et al.
Publicado: (2022)

Policies and practices in Nigeria’s pharmaceutical sector: A mixed methods exploration of stakeholders’ perspectives on strategic reforms
por: Adigwe, Obi Peter
Publicado: (2023)

A personal perspective on medicinal and pharmaceutical chemistry
por: Banik, Bimal K.
Publicado: (2014)

Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings
por: Sendyona, Semukaya, et al.
Publicado: (2016)

Critical Care Medicine: Bangladesh Perspective
por: Mostafa, Nafseen
Publicado: (2018)

Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland
por: O’Leary, A., et al.
Publicado: (2015)

Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives
por: de Vries, Jeroen K., et al.
Publicado: (2018)

Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2012)

Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines
por: Mehralian, Gholamhossein, et al.
Publicado: (2015)

Cardiac repolarization abnormalities in children with familial Mediterranean fever
por: Farag, Yomna, et al.
Publicado: (2022)

Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review
por: Martignetti, Lucas, et al.
Publicado: (2022)

The Dutch chain approach on pharmaceuticals in water: Stakeholders acting together to reduce the environmental impact of pharmaceuticals
por: Moermond, Caroline T. A., et al.
Publicado: (2022)

Novel models to improve access to medicines for chronic diseases in South Africa: an analysis of stakeholder perspectives on community-based distribution models
por: Magadzire, Bvudzai Priscilla, et al.
Publicado: (2016)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017)

Exploring the Influence of the Coronavirus Disease 2019 Pandemic on the Accessibility of Rehabilitation Services Provided to Children with Disabilities: A Cross-Sectional Study
por: Elkholi, Safaa Mostafa, et al.
Publicado: (2023)

World Health Organization Surgical Safety Checklist with Addition of Infection Control Items: Intervention Study in Egypt
por: El-Shafei, Arwa M. Hosny, et al.
Publicado: (2019)

Deconstructing and Historicizing Access to Medicines: The Changing Priority of Pharmaceutical Governance in China
por: Li, Lantian
Publicado: (2021)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Stakeholder Perspectives on COVID-19 and Household Water Access in Vulnerable Communities in the Mekong Region
por: Lebel, Louis, et al.
Publicado: (2022)

The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia
por: Lu, Christine Y, et al.
Publicado: (2007)

Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis
por: McMullan, Patrick, et al.
Publicado: (2018)

From growers to patients: Multi-stakeholder views on the use of, and access to medicinal cannabis in Australia
por: Erku, Daniel, et al.
Publicado: (2022)

Optimal low voltage ride through of wind turbine doubly fed induction generator based on bonobo optimization algorithm
por: Mostafa, M. Abdelateef, et al.
Publicado: (2023)

Supraorbital Nerve Stimulation for Facial Pain
por: Elkholy, Mohamed Amgad Elsayed, et al.
Publicado: (2023)

Changes in Whey Proteome between Mediterranean and Murrah Buffalo Colostrum and Mature Milk Reflect Their Pharmaceutical and Medicinal Value
por: Abdel-Hamid, Mahmoud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8g12bcsgtqn5laj59koa7mugbd